Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ambrose

Showing results (201-210 of 250) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|May 20, 2009
Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infectionOlanrewaju O Okusanya, Sujata M Bhavnani, Jeffrey Hammel, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2007
Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulationChristopher M Rubino, Lei Ma, Sujata M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2014
Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection modelBrian D VanScoy, Rodrigo E Mendes, Mariana Castanheira, et al.
The Journal of Infectious Diseases|May 6, 2017
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet NeedsHelen W Boucher, Paul G Ambrose, H F Chambers, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2024
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infectionsSujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2011
Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemiaDavid Andes, Paul G Ambrose, Jeffrey P Hammel, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2019
Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumoniaSujata M Bhavnani, Li Zhang, Jeffrey P Hammel, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2023
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric ApproachesA J Lepak, M Trang, J P Hammel, et al.
Antimicrobial Agents and Chemotherapy|May 22, 2019
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative InfectionsLaura McEntee, Adam Johnson, Nicola Farrington, et al.
Surgical Infections|February 27, 2016
Beyond Blood Culture and Gram Stain Analysis: A Review of Molecular Techniques for the Early Detection of Bacteremia in Surgical PatientsMichelle H Scerbo, Heidi B Kaplan, Anahita Dua, et al.
Pageof 25

Showing results (201-210 of 250) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|May 20, 2009
Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infectionOlanrewaju O Okusanya, Sujata M Bhavnani, Jeffrey Hammel, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2007
Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulationChristopher M Rubino, Lei Ma, Sujata M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2014
Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection modelBrian D VanScoy, Rodrigo E Mendes, Mariana Castanheira, et al.
The Journal of Infectious Diseases|May 6, 2017
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet NeedsHelen W Boucher, Paul G Ambrose, H F Chambers, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2024
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infectionsSujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2011
Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemiaDavid Andes, Paul G Ambrose, Jeffrey P Hammel, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2019
Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumoniaSujata M Bhavnani, Li Zhang, Jeffrey P Hammel, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2023
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric ApproachesA J Lepak, M Trang, J P Hammel, et al.
Antimicrobial Agents and Chemotherapy|May 22, 2019
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative InfectionsLaura McEntee, Adam Johnson, Nicola Farrington, et al.
Surgical Infections|February 27, 2016
Beyond Blood Culture and Gram Stain Analysis: A Review of Molecular Techniques for the Early Detection of Bacteremia in Surgical PatientsMichelle H Scerbo, Heidi B Kaplan, Anahita Dua, et al.
Pageof 25